A »To locate a contract manufacturer for over-the-counter (OTC) medicines in the United Kingdom, you will need to identify organisations that are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) and operate in full compliance with Good Manufacturing Practice (GMP) standards. The UK market offers a range of capabilities from large-scale pharmaceuticals to specialised contract development and manufacturing organisations (CDMOs). A robust starting point is to consult the MHRA’s public register of manufacturing sites, which lists all authorised facilities and can be filtered by product type and activity. Additionally, industry bodies such as the Association of the British Pharmaceutical Industry (ABPI), the British Generic Manufacturers Association (BGMA), and the Consumer Healthcare Products Association (PAGB) maintain member directories that include contract manufacturing services. For OTC-specific products, it is prudent to seek CDMOs with proven experience in monographed or traditional herbal medicines, as these often require distinct regulatory pathways. When evaluating potential partners, consider their technical capabilities for your desired dosage forms—whether tablets, capsules, oral liquids, creams, gels, or medicated lozenges—as well as their ability to handle primary and secondary packaging, stability testing, and batch release. Many UK manufacturers also offer formulation development and regulatory support to help navigate the MHRA’s decentralised or national licensing procedures. It is essential to conduct a thorough audit of the manufacturer’s GMP compliance, quality management systems, and supply chain reliability; you may request a copy of their most recent MHRA inspection report or visit their facilities. For small-scale or pilot batches, consider academic spin-outs or innovation hubs associated with universities, which sometimes provide contract services. Business-to-business platforms like PharmaSource or speciality chemical marketplaces can also connect you with vetted UK suppliers. Location near your own distribution network may reduce logistical costs, but regulatory compliance and technical expertise should take precedence. Finally, ensure that any contract manufacturer is willing to enter into a quality agreement that defines responsibilities for raw material sourcing, in-process controls, and finished product testing. By systematically leveraging these channels—regulatory registers, trade associations, direct referrals, and industry expos such as CPhI Worldwide or Pharmapack—you can identify a UK-based contract manufacturer that meets both regulatory strictures and your commercial objectives for OTC medicine production.

A »Hey there

A »To identify a contract manufacturer for over-the-counter (OTC) medicines in the United Kingdom, you must first appreciate the regulatory framework and then leverage a combination of industry directories, trade associations, and professional networks. The Medicines and Healthcare products Regulatory Agency (MHRA) oversees all medicinal products in the UK, and any manufacturer you engage must hold a Manufacturer’s Authorization (MA) and comply with Good Manufacturing Practice (GMP) standards. Consequently, your search should begin with the MHRA’s own public registers—specifically the list of licensed manufacturers and wholesalers—which you can search online by activity type (e.g., “manufacture of medicinal products for human use”). This ensures potential partners are already authorized to handle OTC medicines, which span analgesics, antihistamines, antacids, and cough/cold preparations. Moving beyond the regulator, the United Kingdom is home to numerous specialist pharmaceutical contract development and manufacturing organizations (CDMOs) that routinely handle OTC formulations. Notable examples include Recipharm (with UK sites in Ashford and Manchester), Sterling Pharma Solutions (based in Dudley), PCI Pharma Services (for primary packaging and patient-centric solutions), and CordenPharma (with UK operations in Northumberland). Many of these firms offer end-to-end services from formulation development and stability testing to commercial manufacturing and secondary packaging. To find a broader range of partners, you can consult the trade associations: the Association of the British Pharmaceutical Industry (ABPI) maintains member directories, though its focus is more on prescription medicines; the British Generic Manufacturers Association (BGMA) is valuable for OTC generics; and the Health and Medicines Manufacturing Industry Association (HMMIA) represents small-to-medium manufacturers often proficient in niche OTCs. Additionally, the Pharmaceutical Market Research Group (PMRG) and organisations like Informa publish industry guides such as the “Who’s Who in the UK Pharmaceutical Industry” and the “PharmaSource Directory,” which list contract manufacturers by capability and therapeutic area. Online B2B platforms like PharmaSources.com and Go4Pharma allow you to filter by country, product type, and certification (e.g., ISO 22716 for GMP). Another powerful avenue is attending UK-based pharmaceutical conferences and exhibitions, particularly the CPhI (Convention on Pharmaceutical Ingredients) co-located events in London or Paris, where many UK CDMOs exhibit. Local networking through BioIndustry Association (BIA) events (though Biopharma-focused) or the Regional NHS Innovation Networks may also yield leads, especially for OTC items produced under “Specials” licenses. When assessing candidates, request copies of their current MHRA license, recent GMP inspection reports (MHRA publishes inspection outcomes), and proof of liability insurance. It is critical to execute a detailed Quality Technical Agreement (QTA) that defines specifications, change control, batch release procedures, and stability monitoring in accordance with MHRA guidance for OTCs. Do not overlook smaller, specialized manufacturers that offer flexibility for lower-volume products or unique dosage forms like lozenges, powders, or transdermal patches. Finally, consider the supply chain implications: Brexit has altered UK-EU regulatory alignment, so verify that the manufacturer can import active pharmaceutical ingredients (APIs) and excipients without delays and that they hold a Wholesale Dealer’s Authorization if they will handle customs clearance. By systematically combing through official registers, trade directories, and professional contacts, you can assemble a shortlist of reputable contract manufacturers capable of producing safe, effective, and compliant OTC medicines for the UK market.

No answer available